Acute Coronary Syndrome (ACS) is a leading cause of cardiovascular mortality and simple hematological markers may help predict outcomes. Baseline laboratory parameters were recorded and patients were followed for in-hospital mortality and ICU requirement in this prospective study of 140 ACS patients admitted during 2024,. The mean age was 59.3 ± 10.7 years, with 65.7% males, and adverse outcomes occurred in 8.6%. Non-survivors had significantly higher RDW, mean platelet volume (MPV) and platelet distribution width (PDW). RDW-SD showed the highest predictive accuracy, followed by NLR and RDW-CV. Multivariate analysis identified creatinine, RDW, PDW, NLR, MPV, and urea as independent mortality predictors, while higher hemoglobin was protective, supporting the role of routine, low-cost markers in early ACS risk stratification.